Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lantbrukarnas Ekonomi-Aktiebolag in connection with the sale of LRF Konsult AB
Mandate

Vinge advises Lantbrukarnas Ekonomi-Aktiebolag in connection with the sale of LRF Konsult AB

March 13, 2018 Employment and Benefits

Vinge has advised Lantbrukarnas Ekonomi-Aktiebolag in connection with the sale of a majority of its consultancy operations in LRF Konsult AB.

LRF Konsult has 75 000 small enterprisers as customers and 130 offices all around the country, and had most recently a turnover of approximately SEK 1 billion. Lantbrukarnas Ekonomi-Aktiebolag will continue to be a minority owner and will hold approximately one fourth of the shares. The acquisition is conditional upon approval by the Swedish Competition Authority.

Vinge’s team consisted primarily of responsible partner Christina Kokko as well as partners Eva Fredrikson and Carl Johan af Petersens as well as associates Alex Miler, Marith Welin-Berger, Malin Malm Waerme and Christoffer Nordin.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025